Table 1 Clinic-pathologic characteristics and MYCN amplification of study population
Patients (n = 44) | % | MYCN | |
|---|---|---|---|
amp | No-amp | ||
Gender | (p = 0.604) (R = -0.090) | ||
Male (21) | 48 | 3 | 12 |
Female (23) | 52 | 5 | 13 |
Age at diagnosis (months) | (p = 0.023) (R = 0.396) | ||
< 18 (29) | 66 | 3 | 20 |
> 18 (15) | 34 | 5 | 5 |
Risk | (p = 0.003) (R = 0.516) | ||
Intermediate, high (23) | 52 | 8 | 10 |
Low (21) | 48 | 8 | 0 |
Stage | (p = 0.002) (R = 0.550) | ||
Metastatic (12) | 27 | 6 | 4 |
Non-metastatic (32) | 73 | 2 | 21 |
Stage | (p = 0.018) (R = 0.412) | ||
III, IV (17) | 39 | 6 | 7 |
non-III, non-IV (27) | 61 | 2 | 18 |
Stage | (p = 0.000) (R = 0.606) | ||
IV (13) | 30 | 6 | 3 |
non-IV (31) | 70 | 2 | 22 |
Survival | (p = 0.000) (R = 0.650) | ||
Dead (10) | 23 | 5 | 1 |
Alive (34) | 77 | 3 | 24 |